[1]Patent:WO2010/132999,2010,A1.Locationinpatent:Page/Pagecolumn181
[2]Patent:WO2015/97123,2015,A1.Locationinpatent:Page/Pagecolumn132;133;164
[3]JournalofMedicinalChemistry,2020,vol.63,p.13762-13795
[1]Patent:WO2015/97123,2015,A1
400755-43-3
84547-61-5
1007517-79-4
1429417-57-1
1296225-26-7
1006464-74-9
1185298-02-5 | 3-(2,5-Difluorophenoxy)pyrrolidine hydrochloride | AA0092DM | MFCD09879248
1206982-50-4 | 2-Ethyl-5-oxazolemethanamine | AA0092QL | MFCD16300702
1070892-90-8 | methyl 4-chloro-2-methoxy-5-(tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate | AA0093HJ | MFCD19441823
1117843-17-0 | 4-Chloro-2-MethylbenzaMide | AA0093WJ | MFCD12922943
1049727-56-1 | (3S,4R)-4-(4-Fluorophenyl)pyrrolidine-3-carboxylic acid hydrochloride | AA00943P | MFCD06659259
1033132-02-3 | 1-Propyl-3-(trifluoromethyl)pyrazole | AA00947I | MFCD16619915
1203499-48-2 | 2-Amino-6-methyl-1,8-naphthyridine-3-carbonitrile | AA0094EY | MFCD13563080
1209173-54-5 | (1-(3-Chlorophenyl)cyclopropyl)methanamine hydrochloride | AA0094PS | MFCD09864779
1132093-70-9 | Dasatinib-d8 | AA00956U | MFCD15071210
1020747-85-6 | 2-Cyclopropylisonicotinonitrile | AA0095KW | MFCD18089268